Monocyte-derived tumour necrosis factor stimulated gene-6 (TSG-6) alters bone mass via effects on osteoblasts and osteoclasts

Monocyte-derived tumour necrosis factor stimulated gene-6 (TSG-6) alters bone mass via effects on osteoblasts and osteoclasts

Bibliographic Details
Main Authors:	Afrough, S, Mahoney, D, Sabokbar, A, Horwood, N
Format:	Conference item
Published:	2012

Similar Items

TSG-6 regulates bone remodeling through inhibition of osteoblastogenesis and osteoclast activation.
by: Mahoney, D, et al.
Published: (2008)

TSG-6 regulates bone remodelling through inhibition of osteoblastogenesis and osteoclast activation
by: Mahoney, D, et al.
Published: (2008)

TSG-6 inhibits osteoclast activity via an autocrine mechanism and is functionally synergistic with osteoprotegerin
by: Mahoney, D, et al.
Published: (2013)

The role of tumour necrosis factor alpha stimulated gene-6 on bone
by: Afrough, S
Published: (2016)

TSG-6 Acts Synergisticly with OPG to Inhibit Bone Resorption
by: Mahoney, D, et al.
Published: (2008)

TSG-6, new regulator of bone remodelling
by: Mahoney, D, et al.
Published: (2007)

TSG-6: a new regulator of bone remodelling
by: Day, A, et al.
Published: (2008)

TSG-6 inhibits osteoclast activity via an autocrine mechanism and is functionally synergistic with osteoprotegerin.
by: Mahoney, D, et al.
Published: (2011)

TSG-6 inhibits osteoclast activity via an autocrine mechanism and is functionally synergistic with osteoprotegerin.
by: Mahoney, D, et al.
Published: (2011)

Human osteoblasts support human monocyte-osteoclast differentiation: Evidence of prostaglandin stimulation
by: Neale, S, et al.
Published: (1999)

Human osteoblasts support human monocyte-osteoclast differentiation
by: Neale, S, et al.
Published: (1998)

The effect of interleukin-1β, tumour necrosis factor α and particle phagocytosis on monocyte-osteoclast differentiation
by: Wang, W, et al.
Published: (1999)

TSG-6: AN AUTOCRINE REGULATOR OF INFLAMMATORY JOINT DISEASE?
by: Swales, C, et al.
Published: (2010)

Plasticity of the TSG-6 HA-binding loop and mobility in the TSG-6-HA complex revealed by NMR and X-ray crystallography.
by: Higman, V, et al.
Published: (2007)

Macrophage colony-stimulating factor and interleukin-6 release by periprosthetic cells stimulates osteoclast formation and bone resorption.
by: Neale, S, et al.
Published: (1999)

Osteoblasts and osteoclasts: an important switch of tumour cell dormancy during bone metastasis
by: Rongchen Dai, et al.
Published: (2022-10-01)

The crystal structure of the CUB module from human TSG-6
by: Briggs, D, et al.
Published: (2008)

Human tumour associated macrophages are capable of osteoclastic differentiation and bone resorption
by: Quinn, J, et al.
Published: (1997)

Osteoblast-Osteoclast Communication and Bone Homeostasis
by: Jung-Min Kim, et al.
Published: (2020-09-01)

Human osteoclast formation and bone resorption by monocytes and synovial macrophages in rheumatoid arthritis.
by: Fujikawa, Y, et al.
Published: (1996)

Human mesenchymal tumour-associated macrophages differentiate into osteoclastic bone-resorbing cells.
by: Yang, T, et al.
Published: (2002)

Metal particle-containing human monocytes differentiate into osteoclastic bone resorbing cells
by: Neale, S, et al.
Published: (1999)

TSG-6 modulates the interaction between hyaluronan and cell surface CD44.
by: Lesley, J, et al.
Published: (2004)

The human osteoclast precursor circulates in the monocyte fraction.
by: Fujikawa, Y, et al.
Published: (1996)

Down regulation of SCARA5 modulates bone density through increased osteoblast activity
by: Mahoney, D, et al.
Published: (2013)

Akt1 in osteoblasts and osteoclasts controls bone remodeling.
by: Naohiro Kawamura, et al.
Published: (2007-10-01)

Circ_0008542 in osteoblast exosomes promotes osteoclast-induced bone resorption through m6A methylation
by: Wei Wang, et al.
Published: (2021-06-01)

Breast cancer cells interact with osteoblasts to support osteoclast formation.
by: Thomas, R, et al.
Published: (1999)

IL-6 induces human osteoclast formation and bone resorption independent of RANK/RANKL interaction
by: Kudo, O, et al.
Published: (2001)

Development of an osteoblast/osteoclast co-culture derived by human bone marrow stromal cells and human monocytes for biomaterials testing
by: H Worch, et al.
Published: (2011-01-01)

Brain Ischemic Tolerance Triggered by Preconditioning Involves Modulation of Tumor Necrosis Factor-α-Stimulated Gene 6 (TSG-6) in Mice Subjected to Transient Middle Cerebral Artery Occlusion
by: Chiara Di Santo, et al.
Published: (2024-09-01)

The role of light in osteoclast formation and pathological bone resorption in rheumatoid arthritis
by: Athanasou, NA, et al.
Published: (2017)

Osteoclast-Derived Extracellular Vesicles: Novel Regulators of Osteoclastogenesis and Osteoclast–Osteoblasts Communication in Bone Remodeling
by: Feng-Lai Yuan, et al.
Published: (2018-05-01)

Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells.
by: Horwood, N, et al.
Published: (1998)

Formation of human osteoclasts from a subpopulation of circulating monocytes
by: Fujikawa, Y, et al.
Published: (1996)

Human osteoclasts differentiate from a subpopulation of circulating monocytes.
by: Fujikawa, Y, et al.
Published: (1996)

The effect of macrophage-colony stimulating factor and other humoral factors (interleukin-1, -3, -6, and -11, tumor necrosis factor-alpha, and granulocyte macrophage-colony stimulating factor) on human osteoclast formation from circulating cells.
by: Fujikawa, Y, et al.
Published: (2001)

Human osteoclast ontogeny and pathological bone resorption.
by: Athanasou, N, et al.
Published: (1999)

Monocytes control mesenchymal stem cell differentation towards osteoblasts
by: Nicolaidou, V, et al.
Published: (2009)

SirT1 regulates bone mass in vivo through regulation of osteoblast and osteoclast differentiation
by: Zainabadi, Kayvan
Published: (2009)